Dennis Cho, Senior Vice President, Chief Legal Officer and Corporate Secretary of Twist Bioscience Corp, filed a Form 4 on November 18, 2026, disclosing two transactions in common stock dated November 16, 2026.
Key Highlights
- Mandatory tax-withholding sale: Cho disposed of 5,427 shares of common stock at $103.688 per share on November 16, 2026, to cover tax withholding obligations tied to vesting Performance Stock Units (PSUs).
- RSU award granted: Cho acquired 7,045 restricted stock units (RSUs) at $0 on November 16, 2026, vesting in 1/16th increments on each quarterly anniversary of that date over a 48-month period.
- Post-transaction ownership: Following both transactions, Cho directly beneficially owned 87,283 shares of common stock.
- Sell-to-cover designation: According to the filing, the 5,427-share sale was mandated by the issuer's equity incentive plan election and "do not represent discretionary trades by the Reporting Person."
- Filing signed by attorney-in-fact: The form was signed by Kendra Fox as attorney-in-fact for Dennis Cho on November 18, 2026.
Cho's November 2026 RSU Grant and PSU-Related Share Disposition at Twist Bioscience
According to the Form 4 filed with the SEC on November 18, 2026, Dennis Cho, who holds the title of Senior Vice President, Chief Legal Officer and Corporate Secretary at Twist Bioscience Corp (NASDAQ:TWST), reported two transactions in the company's common stock, both dated November 16, 2026. The filing covers non-derivative securities only, with no derivative security transactions reported in Table II.
The first transaction was a disposition (transaction code S) of 5,427 shares at a price of $103.688 per share. The filing states this sale "represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Performance Stock Units (PSUs)." The filing further specifies that these sales "are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a 'sell to cover' transaction." Following this disposal, Cho held 80,238 shares directly.
The second transaction was an acquisition (transaction code A) of 7,045 RSUs at $0, representing a new restricted stock unit award. According to the filing, 1/16th of the total RSUs vest on each quarterly anniversary of November 16, 2026, over a total vesting period of 48 months, subject to Cho's continuous service through each vesting date. After this award, Cho's direct beneficial ownership increased to 87,283 shares of common stock.
What Was Disclosed
The filing disclosed a mandatory PSU-related tax-withholding sale of 5,427 shares at $103.688 and a new RSU award of 7,045 shares granted to Dennis Cho on November 16, 2026, resulting in direct beneficial ownership of 87,283 shares of Twist Bioscience Corp common stock.



Please wait processing your request...